Developer docs
API playgroundTry for free, no card

Search company profiles

Oniris Ronflement

Full company profile

uuid02lrzjg

Namestring
Oniris Ronflement
Legal namestring
ONIRIS SAS
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Oniris Ronflement (legal entity: ONIRIS SAS) is a French medical device company founded in 2008 by a dental surgeon, headquartered at 147 Avenue Paul Doumer, Rueil-Malmaison (Hauts-de-Seine), France (SIRET 533 427 548 R.C.S. Nanterre). The company develops, manufactures, and sells mandibular advancement orthoses (MADs) — bi-bloc oral appliances that mechanically advance the lower jaw during sleep to open the upper airway and prevent the obstruction that causes snoring and obstructive sleep apnea (SAHOS). It operates as a hybrid consumer / professional medical-device provider: the entry-level ONIRIS Classic (€69 incl. VAT) and ONIRIS Plus (€99) are sold direct-to-consumer for self-fitting, while the professionally-fitted ONIRIS Pro (€200–€300) and the fully custom TALI (€600–€800) are fitted by dental surgeons and sleep physicians for clinically diagnosed SAHOS patients.

The core technology is a patented thermoformable bi-bloc oral appliance with adjustable advancement bars (up to 11 mm on the Plus model) and a self-fitting impression process that enables home use without a dental visit for the standard line. ONIRIS Plus adds reinforced advancement bars for bruxism sufferers and an extended 24-month lifespan (vs. 12 months for Classic). Both consumer SKUs and professional SKUs share the same patented dual-block architecture, which preserves full lateral jaw movement. The firm has treated 300,000+ patients in France (per company website) and reports a 94% satisfaction rate. Clinical evidence is anchored by the IRIS multicenter randomized controlled trial (>500 patients) published in THORAX (BMJ, Impact Factor 10), which demonstrated non-inferiority of the thermoformable device versus custom-made orthoses on AHI, snoring, quality of life (SF-12 MCS/PCS), blood pressure, daytime sleepiness (Epworth, Pichot), depression, and compliance after 12 months.

Oniris operates a dual go-to-market: (i) direct-to-consumer e-commerce via its own oniris-ronflement.fr site for Classic, Plus, and bundles (€69–€119) with 7-day withdrawal and La Poste/FedEx shipping; and (ii) a professional channel in which dental surgeons and sleep specialists prescribe ONIRIS Pro and TALI — a channel that, after HAS validation in 2019, opens French Sécurité Sociale reimbursement under the LPP framework. Pharmacy distribution is handled through major French wholesalers (Alliance Healthcare, CERP, Alcura, Oxypharm, ALSD), with pharmacists acting as frontline screening for snoring patients (an estimated 40 of 100 pharmacy customers). The device is Class I CE-marked, ISO 13485 certified, FDA-cleared (USA, 2016), and ANVISA-approved (Brazil, 2019). The company has expanded internationally since 2015 and reports presence across multiple European countries and globally. Ownership remains private with no disclosed external venture or private equity funding; the shareholder base is described as including physicians and patients, and the company previously benefited from Young Innovative Company (JEI) status.

Short descriptiontext

Oniris Ronflement (ONIRIS SAS) develops and sells thermoformable mandibular advancement oral devices for snoring and obstructive sleep apnea, distributing via direct-to-consumer e-commerce, French pharmacy networks, and dental/sleep specialists across Europe, the US and Brazil. Founded 2008.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRueil-malmaison, France
HQ citystring
Rueil-malmaison
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mandibular advancement devices, snoring treatment devices, sleep apnea oral appliances, anti-snoring mouthpieces, custom dental orthoses
Industry1 code
PRIMARYHLABABAI
Sleep & Airway Orthodontics (OSA Appliances/Expansion)
Healthcare & Life Sciences/Dental Care Services/Orthodontics & Dentofacial Orthopedics
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Sleep Apnea Medical Devices
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Direct e-commerce sales of oral appliances
TypeOne Time License
Description

Oniris sells its mandibular advancement orthoses (ONIRIS Classic, ONIRIS Plus, bundles) directly to consumers through its e-commerce website at fixed unit prices, with no subscription or recurring revenue model — customers purchase a device that lasts 12–24 months depending on the model.

oniris-ronflement.fr
2Professional dental/sleep specialist channel
TypeOne Time License
Description

ONIRIS Pro and TALI orthoses are provided to dental specialists and sleep physicians who fit and prescribe the devices to patients, with the TALI model manufactured to order by a trained dentist and ONIRIS Pro also requiring professional fitting. These channels serve patients with clinically diagnosed sleep apnea and enable social security reimbursement.

oniris-ronflement.fr
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Marketing or Sales, Personnel, Technology or R&D, Others
Pricing details6 tiers
1Orthèse ONIRIS® (Classic) — entry-level thermoformable mandibular advancement device
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

€69.00 incl. VAT (TTC). Features: thermoformable custom impression, bi-bloc system, clinically proven efficacy, up to 12-month lifespan.

oniris-ronflement.fr
2Orthèse ONIRIS PLUS® — enhanced comfort and durability model
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

€99.00 incl. VAT (TTC). Enhanced features vs Classic: reinforced biellettes for bruxers, advancement up to 11mm, lifespan up to 24 months, optimized comfort.

oniris-ronflement.fr
3ONIRIS® + Nitradine® — orthosis bundle with antibacterial cleaning solution
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

€84.00 incl. VAT (TTC). Includes standard ONIRIS orthosis plus Nitradine antibacterial cleaning solution for hygiene and device longevity.

oniris-ronflement.fr
42 Orthèses ONIRIS® — dual-pack for household sharing or replacement
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

€119.00 incl. VAT (TTC). Two ONIRIS Classic orthoses, offering savings vs two individual purchases at €138.

oniris-ronflement.fr
5ONIRIS Pro — professionally fitted device with Health Authority validation
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Price range €200–€300; LPP tariff (Sécurité Sociale reimbursement rate): €69. Requires fitting by a trained dentist. Validated by Haute Autorité de Santé for sleep apnea treatment. Lifespan 18–24 months.

oniris-ronflement.fr
6TALI — custom-made mandibular advancement orthosis
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Price range €600–€800; LPP tariff (Sécurité Sociale reimbursement rate): €459. Requires fitting by a trained dentist. Manufacturing lead time 3–9 months. Lifespan 5 years.

oniris-ronflement.fr
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Oniris Plus
Description

Premium mandibular advancement device with enhanced comfort, reinforced connectors for bruxism sufferers, and lifespan up to 24 months.

oniris-ronflement.fr
+3 more records
Core offering1 text field

Oniris Ronflement (legal entity ONIRIS SAS) designs, manufactures and sells mandibular advancement oral devices used to reduce snoring and treat mild-to-moderate obstructive sleep apnea. The company operates a dual-channel model: a direct-to-consumer range (ONIRIS and ONIRIS Plus) sold online at fixed retail prices, and a professional range (ONIRIS Pro and TALI by ONIRIS) distributed through dentists, sleep specialists, ENT doctors, orthodontists and pharmacies, often eligible for French social-security reimbursement (CPAM/LPPR).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 300,000+ patients treated with ONIRIS orthoses in France
+4 more records
Product overview1 text field

Oniris Ronflement offers a portfolio of mandibular advancement orthoses (orthèses d'avancée mandibulaire) for treating snoring and obstructive sleep apnea. The portfolio includes the entry-level Orthèse ONIRIS® (69€), the enhanced Orthèse Oniris Plus® (99€) with reinforced components and extended lifespan, the dentist-fitted Orthèse Oniris Pro® (200–300€), and the fully custom-made Orthèse TALI (600–800€). All devices share the same patented dual-block technology with thermoformable custom imprint and are clinically validated. Accessories include a 2-unit bundle and an ONIRIS® + Nitradine® hygiene kit. The products are Class I medical devices with CE marking, FDA and ANVISA approvals, and ISO 13485 certification.

Product and service4 records
1ONIRIS
CategoryConsumer anti-snoring oral device
2ONIRIS Plus
CategoryConsumer anti-snoring oral device
3ONIRIS Pro
CategoryProfessional oral medical device
4TALI by ONIRIS
CategoryPharmacy-dispensed oral medical device
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Alliance Healthcare is a major pharmaceutical wholesale and distribution company in France. Oniris relies on Alliance Healthcare as part of its pharmacy distribution network to supply ONIRIS orthoses to pharmacies across France, ensuring quality service and advisory support for pharmacists.

2CERP
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

CERP (Centrale d'Exportation et de Répartition Pharmaceutique) is a French pharmaceutical distribution cooperative. Oniris partners with CERP to distribute its orthoses to pharmacy customers, ensuring broad national coverage and supply chain reliability.

oniris-ronflement.fr
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Alcura is a pharmaceutical distribution company serving pharmacies in France. Oniris includes Alcura in its pharmacy distribution network to reach pharmacists and patients.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Oxypharm is a pharmacy-focused distribution partner in France. Oniris partners with Oxypharm as part of its strategy to make ONIRIS orthoses accessible through pharmacy retail locations nationwide.

5ALSD
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

ALSD is a pharmaceutical wholesale partner in the Oniris pharmacy distribution network. The company supports the supply of ONIRIS anti-snoring orthoses to pharmacies.

oniris-ronflement.fr
6CHU de Grenoble
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CHU de Grenoble (University Hospital of Grenoble) participated as a leading clinical research center in the IRIS multicenter randomized controlled trial comparing ONIRIS orthoses to custom-made devices. Professor Pépin from CHU Grenoble led scientific communications on the 1-year clinical results published in THORAX.

oniris-ronflement.fr
7CHU de Montpellier
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CHU de Montpellier was a key clinical partner in the IRIS multicenter study evaluating ONIRIS mandibular advancement orthoses against custom-made devices for sleep apnea treatment.

oniris-ronflement.fr
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Hôpital Bretonneau, part of the Assistance Publique – Hôpitaux de Paris (AP-HP), was a clinical research partner in the IRIS multicenter trial for ONIRIS orthoses.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major CPAP and sleep apnea device manufacturer. Competes indirectly via CPAP dominance in OSA treatment and shares sleep specialist/dental channels for alternative therapies.

TypeDirect peer
Description

Australia-based global leader in custom-made mandibular advancement devices for OSA. Direct competitor in the MAD category with similar dentist-fitted distribution model and reimbursement pathways across multiple geographies.

TypeEmerging player
Description

Chinese manufacturer of CPAP and oral appliances for sleep apnea with growing international distribution. Emerging competitor with both CPAP and MAD offerings targeting similar dentist and sleep specialist channels.

TypeBroad incumbent
Description

Global leader in CPAP devices and broader sleep-disordered breathing solutions. Competes with Oniris in OSA treatment, particularly for moderate-to-severe cases where CPAP remains the gold standard, and overlaps in sleep clinic distribution channels.

TypeDirect peer
Description

US manufacturer of the TAP (Thornton Adjustable Positioner) family of custom and semi-custom MADs for snoring and OSA. Direct competitor in the professional dental-fitted MAD segment.

TypeDirect peer
Description

US-based maker of the Pharyngol anti-snoring oral device. Competes in the direct-to-consumer and dentist-fitted anti-snoring MAD segment with similar positioning around non-custom thermoformable technology.

TypeDirect peer
Description

Canadian manufacturer of custom-made CAD/CAM mandibular advancement devices (Panthera Classic, Panthera X3). Competes in the dentist-fitted MAD market with similar claims of clinical validation and reimbursement.

TypeOthers
Description

Large US dental lab and manufacturer offering custom MADs (e.g., Silent Nite, TAP) through dentists. Adjacent competitor in dental-fitted OSA appliances with much broader dental products portfolio.

TypeDirect peer
Description

US-based manufacturer of precision oral appliance therapy devices for OSA. Competes in the same mandibular advancement device category serving sleep specialists and dentists, with FDA-cleared devices.

TypeDirect peer
Description

Swiss manufacturer of thermoformable mandibular advancement devices for snoring and sleep apnea. Closest head-to-head peer — competing in the same self-fitting thermoformed MAD category with similar value proposition of clinical efficacy at lower cost than custom devices.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Oniris Ronflement

Sleep Apnea Medical Devicesoniris-ronflement.fr

Oniris Ronflement (ONIRIS SAS) develops and sells thermoformable mandibular advancement oral devices for snoring and obstructive sleep apnea, distributing via direct-to-consumer e-commerce, French pharmacy networks, and dental/sleep specialists across Europe, the US and Brazil. Founded 2008.

What Oniris Ronflement does

Oniris Ronflement (legal entity: ONIRIS SAS) is a French medical device company founded in 2008 by a dental surgeon, headquartered at 147 Avenue Paul Doumer, Rueil-Malmaison (Hauts-de-Seine), France (SIRET 533 427 548 R.C.S. Nanterre). The company develops, manufactures, and sells mandibular advancement orthoses (MADs) — bi-bloc oral appliances that mechanically advance the lower jaw during sleep to open the upper airway and prevent the obstruction that causes snoring and obstructive sleep apnea (SAHOS). It operates as a hybrid consumer / professional medical-device provider: the entry-level ONIRIS Classic (€69 incl. VAT) and ONIRIS Plus (€99) are sold direct-to-consumer for self-fitting, while the professionally-fitted ONIRIS Pro (€200–€300) and the fully custom TALI (€600–€800) are fitted by dental surgeons and sleep physicians for clinically diagnosed SAHOS patients.

The core technology is a patented thermoformable bi-bloc oral appliance with adjustable advancement bars (up to 11 mm on the Plus model) and a self-fitting impression process that enables home use without a dental visit for the standard line. ONIRIS Plus adds reinforced advancement bars for bruxism sufferers and an extended 24-month lifespan (vs. 12 months for Classic). Both consumer SKUs and professional SKUs share the same patented dual-block architecture, which preserves full lateral jaw movement. The firm has treated 300,000+ patients in France (per company website) and reports a 94% satisfaction rate. Clinical evidence is anchored by the IRIS multicenter randomized controlled trial (>500 patients) published in THORAX (BMJ, Impact Factor 10), which demonstrated non-inferiority of the thermoformable device versus custom-made orthoses on AHI, snoring, quality of life (SF-12 MCS/PCS), blood pressure, daytime sleepiness (Epworth, Pichot), depression, and compliance after 12 months.

Oniris operates a dual go-to-market: (i) direct-to-consumer e-commerce via its own oniris-ronflement.fr site for Classic, Plus, and bundles (€69–€119) with 7-day withdrawal and La Poste/FedEx shipping; and (ii) a professional channel in which dental surgeons and sleep specialists prescribe ONIRIS Pro and TALI — a channel that, after HAS validation in 2019, opens French Sécurité Sociale reimbursement under the LPP framework. Pharmacy distribution is handled through major French wholesalers (Alliance Healthcare, CERP, Alcura, Oxypharm, ALSD), with pharmacists acting as frontline screening for snoring patients (an estimated 40 of 100 pharmacy customers). The device is Class I CE-marked, ISO 13485 certified, FDA-cleared (USA, 2016), and ANVISA-approved (Brazil, 2019). The company has expanded internationally since 2015 and reports presence across multiple European countries and globally. Ownership remains private with no disclosed external venture or private equity funding; the shareholder base is described as including physicians and patients, and the company previously benefited from Young Innovative Company (JEI) status.

Oniris Ronflement firmographics

Firmographics
Name
Oniris Ronflement
Legal name
ONIRIS SAS
Website
https://oniris-ronflement.fr
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
1–10 employees
Short description
Oniris Ronflement (ONIRIS SAS) develops and sells thermoformable mandibular advancement oral devices for snoring and obstructive sleep apnea, distributing via direct-to-consumer e-commerce, French pharmacy networks, and dental/sleep specialists across Europe, the US and Brazil. Founded 2008.
Ownership category
akta.pro rank

Oniris Ronflement industry classification

Industry
Product category
Sleep Apnea Medical Devices
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLABABAI
Sleep & Airway Orthodontics (OSA Appliances/Expansion)
Healthcare & Life Sciences/Dental Care Services/Orthodontics & Dentofacial Orthopedics

Keywords

  • Mandibular advancement devices
  • Snoring treatment devices
  • Sleep apnea oral appliances
  • Anti-snoring mouthpieces
  • Custom dental orthoses

Where Oniris Ronflement is headquartered

Location

Headquarters

HQ city
Rueil-malmaison
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Oniris Ronflement business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Marketing or Sales, Personnel, Technology or R&D, Others

Revenue model

  1. Direct e-commerce sales of oral appliances: Oniris sells its mandibular advancement orthoses (ONIRIS Classic, ONIRIS Plus, bundles) directly to consumers through its e-commerce website at fixed unit prices, with no subscription or recurring revenue model — customers purchase a device that lasts 12–24 months depending on the model.
  2. Professional dental/sleep specialist channel: ONIRIS Pro and TALI orthoses are provided to dental specialists and sleep physicians who fit and prescribe the devices to patients, with the TALI model manufactured to order by a trained dentist and ONIRIS Pro also requiring professional fitting. These channels serve patients with clinically diagnosed sleep apnea and enable social security reimbursement.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goOrthèse ONIRIS® (Classic) — entry-level thermoformable mandibular advancement device
One time/ perpetual licensePay-as-you-goOrthèse ONIRIS PLUS® — enhanced comfort and durability model
One time/ perpetual licensePay-as-you-goONIRIS® + Nitradine® — orthosis bundle with antibacterial cleaning solution
One time/ perpetual licensePay-as-you-go2 Orthèses ONIRIS® — dual-pack for household sharing or replacement
One time/ perpetual licenseMulti-year contractONIRIS Pro — professionally fitted device with Health Authority validation
One time/ perpetual licenseMulti-year contractTALI — custom-made mandibular advancement orthosis

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Oniris Ronflement product offering

Product offering

Core offering

Oniris Ronflement (legal entity ONIRIS SAS) designs, manufactures and sells mandibular advancement oral devices used to reduce snoring and treat mild-to-moderate obstructive sleep apnea. The company operates a dual-channel model: a direct-to-consumer range (ONIRIS and ONIRIS Plus) sold online at fixed retail prices, and a professional range (ONIRIS Pro and TALI by ONIRIS) distributed through dentists, sleep specialists, ENT doctors, orthodontists and pharmacies, often eligible for French social-security reimbursement (CPAM/LPPR).

Product overview

Oniris Ronflement offers a portfolio of mandibular advancement orthoses (orthèses d'avancée mandibulaire) for treating snoring and obstructive sleep apnea. The portfolio includes the entry-level Orthèse ONIRIS® (69€), the enhanced Orthèse Oniris Plus® (99€) with reinforced components and extended lifespan, the dentist-fitted Orthèse Oniris Pro® (200–300€), and the fully custom-made Orthèse TALI (600–800€). All devices share the same patented dual-block technology with thermoformable custom imprint and are clinically validated. Accessories include a 2-unit bundle and an ONIRIS® + Nitradine® hygiene kit. The products are Class I medical devices with CE marking, FDA and ANVISA approvals, and ISO 13485 certification.

Differentiator

Problem solved

Functional benefit

Brands

  • Oniris Plus: Premium mandibular advancement device with enhanced comfort, reinforced connectors for bruxism sufferers, and lifespan up to 24 months.
  • Oniris Classique
  • Oniris Pro
  • TALI

Products and services

  • ONIRIS
  • ONIRIS Plus
  • ONIRIS Pro
  • TALI by ONIRIS

Quantifiable outcome

  • 300,000+ patients treated with ONIRIS orthoses in France
  • +4 more outcomes

Companies that use Oniris Ronflement

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Oniris Ronflement technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Oniris Ronflement partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Alliance HealthcarecoreChannel Partner/ Reseller/ DistributorAlliance Healthcare is a major pharmaceutical wholesale and distribution company in France. Oniris relies on Alliance Healthcare as part of its pharmacy distribution network to supply ONIRIS orthoses to pharmacies across France, ensuring quality service and advisory support for pharmacists.
  • CERPcoreChannel Partner/ Reseller/ DistributorCERP (Centrale d'Exportation et de Répartition Pharmaceutique) is a French pharmaceutical distribution cooperative. Oniris partners with CERP to distribute its orthoses to pharmacy customers, ensuring broad national coverage and supply chain reliability.
  • AlcuraminorChannel Partner/ Reseller/ DistributorAlcura is a pharmaceutical distribution company serving pharmacies in France. Oniris includes Alcura in its pharmacy distribution network to reach pharmacists and patients.
  • OxypharmminorChannel Partner/ Reseller/ DistributorOxypharm is a pharmacy-focused distribution partner in France. Oniris partners with Oxypharm as part of its strategy to make ONIRIS orthoses accessible through pharmacy retail locations nationwide.
  • ALSDminorChannel Partner/ Reseller/ DistributorALSD is a pharmaceutical wholesale partner in the Oniris pharmacy distribution network. The company supports the supply of ONIRIS anti-snoring orthoses to pharmacies.
  • CHU de GrenoblecoreStrategic or Co-development PartnerCHU de Grenoble (University Hospital of Grenoble) participated as a leading clinical research center in the IRIS multicenter randomized controlled trial comparing ONIRIS orthoses to custom-made devices. Professor Pépin from CHU Grenoble led scientific communications on the 1-year clinical results published in THORAX.
  • CHU de MontpelliercoreStrategic or Co-development PartnerCHU de Montpellier was a key clinical partner in the IRIS multicenter study evaluating ONIRIS mandibular advancement orthoses against custom-made devices for sleep apnea treatment.
  • Hôpital Bretonneau (AP-HP, Paris)coreStrategic or Co-development PartnerHôpital Bretonneau, part of the Assistance Publique – Hôpitaux de Paris (AP-HP), was a clinical research partner in the IRIS multicenter trial for ONIRIS orthoses.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Oniris Ronflement competitors and assessment

Company assessment

Broad incumbents

  • Philips Respironics: Major CPAP and sleep apnea device manufacturer. Competes indirectly via CPAP dominance in OSA treatment and shares sleep specialist/dental channels for alternative therapies.
  • ResMed: Global leader in CPAP devices and broader sleep-disordered breathing solutions. Competes with Oniris in OSA treatment, particularly for moderate-to-severe cases where CPAP remains the gold standard, and overlaps in sleep clinic distribution channels.

Direct peers

  • SomnoMed: Australia-based global leader in custom-made mandibular advancement devices for OSA. Direct competitor in the MAD category with similar dentist-fitted distribution model and reimbursement pathways across multiple geographies.
  • Airway Management: US manufacturer of the TAP (Thornton Adjustable Positioner) family of custom and semi-custom MADs for snoring and OSA. Direct competitor in the professional dental-fitted MAD segment.
  • Apnea Sciences: US-based maker of the Pharyngol anti-snoring oral device. Competes in the direct-to-consumer and dentist-fitted anti-snoring MAD segment with similar positioning around non-custom thermoformable technology.
  • Panthera Dental: Canadian manufacturer of custom-made CAD/CAM mandibular advancement devices (Panthera Classic, Panthera X3). Competes in the dentist-fitted MAD market with similar claims of clinical validation and reimbursement.
  • ProSomnus Sleep Technologies: US-based manufacturer of precision oral appliance therapy devices for OSA. Competes in the same mandibular advancement device category serving sleep specialists and dentists, with FDA-cleared devices.
  • Oscimed SA: Swiss manufacturer of thermoformable mandibular advancement devices for snoring and sleep apnea. Closest head-to-head peer — competing in the same self-fitting thermoformed MAD category with similar value proposition of clinical efficacy at lower cost than custom devices.

Emerging players

  • BMC Medical: Chinese manufacturer of CPAP and oral appliances for sleep apnea with growing international distribution. Emerging competitor with both CPAP and MAD offerings targeting similar dentist and sleep specialist channels.

Others

  • Glidewell Dental: Large US dental lab and manufacturer offering custom MADs (e.g., Silent Nite, TAP) through dentists. Adjacent competitor in dental-fitted OSA appliances with much broader dental products portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Oniris Ronflement social profiles

Digital presence

Oniris Ronflement compliance and trust

Trust signal

Compliance4 records

Oniris Ronflement financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Oniris Ronflement leadership team

Management profile

Number of profiles

Profiles1 record

Oniris Ronflement subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Oniris Ronflement funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Oniris Ronflement M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oniris Ronflement

What does Oniris Ronflement do?

Oniris Ronflement (legal entity ONIRIS SAS) designs, manufactures and sells mandibular advancement oral devices used to reduce snoring and treat mild-to-moderate obstructive sleep apnea. The company operates a dual-channel model: a direct-to-consumer range (ONIRIS and ONIRIS Plus) sold online at fixed retail prices, and a professional range (ONIRIS Pro and TALI by ONIRIS) distributed through dentists, sleep specialists, ENT doctors, orthodontists and pharmacies, often eligible for French social-security reimbursement (CPAM/LPPR).

Is Oniris Ronflement a public or private company?

Oniris Ronflement is a private company. It is classified as venture growth investor backed and is currently operating.

When was Oniris Ronflement founded?

Oniris Ronflement was founded in 2008. It employs 1 to 10 people.

Where is Oniris Ronflement based?

Oniris Ronflement is headquartered in Rueil-malmaison, France, in the Europe region.

How does Oniris Ronflement make money?

Two revenue lines are on record. Direct e-commerce sales of oral appliances are the primary driver. The others are professional dental/sleep specialist channel.

Who are Oniris Ronflement's main competitors?

Broad incumbents on record are Philips Respironics and ResMed. Direct peers are SomnoMed, Airway Management, Apnea Sciences, Panthera Dental, ProSomnus Sleep Technologies and Oscimed SA. BMC Medical is listed as an emerging player. Glidewell Dental is listed as an others.

Does Oniris Ronflement have an API?

No public API is recorded for Oniris Ronflement.

What industry is Oniris Ronflement in?

Oniris Ronflement's product category is Sleep Apnea Medical Devices. Its primary akta.pro industry code is HLABABAI, Sleep & Airway Orthodontics (OSA Appliances/Expansion). Its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales